Wichtige Literatur und Literatur der Arbeitsgruppe

Literatur der Arbeitsgruppe

1. Akhwale JK, Rohde M, Rohde C, et al. Isolation, characterization and analysis of bacteriophages from the haloalkaline lake Elmenteita, Kenya. PLoS One 2019;14:e0215734.
2. Akhwale JK, Rohde M, Rohde C, et al. Comparative genomic analysis of eight novel haloalkaliphilic bacteriophages from Lake Elmenteita, Kenya. PLoS One 2019;14:e0212102.
3. Beims H, Wittmann J, Bunk B, et al. Paenibacillus larvae-Directed Bacteriophage HB10c2 and Its Application in American Foulbrood-Affected Honey Bee Larvae. Appl Environ Microbiol 2015;81:5411-9.
4. Debarbieux L, Pirnay JP, Verbeken G, et al. A bacteriophage journey at the European Medicines Agency. FEMS Microbiol Lett 2016;363:fnv225.
5. Expert round table on a, re-implementation of bacteriophage t, Sybesma W, et al. Silk Route to the Acceptance and Re-Implementation of Bacteriophage Therapy-Part II. Antibiotics (Basel) 2018;7.
6. Garbe J, Wesche A, Bunk B, et al. Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions. BMC Microbiol 2010;10:301.
7. Hoyle N, Zhvaniya P, Balarjishvili N, et al. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report. Res Microbiol 2018;169:540-2.
8. Huber I, Potapova K, Kuhn A, et al. 1st German Phage Symposium-Conference Report. Viruses 2018;10.
9. Kvachadze L, Balarjishvili N, Meskhi T, et al. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb Biotechnol 2011;4:643-50.
10. Moelling K, Broecker F, Willy C. A Wake-Up Call: We Need Phage Therapy Now. Viruses 2018;10.
11. Pirnay JP, Blasdel BG, Bretaudeau L, et al. Quality and safety requirements for sustainable phage therapy products. Pharm Res 2015;32:2173-9.
12. Rohde C, Resch G, Pirnay JP, et al. Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains. Viruses 2018;10.
13. Rohde C, Wittmann J, Kutter E. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria. Surg Infect (Larchmt) 2018;19:737-44.
14. Selezska K, Kazmierczak M, Musken M, et al. Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environ Microbiol 2012;14:1952-67.
15. Vogt D, Sperling S, Tkhilaishvili T, Trampuz A, Pirnay JP, Willy C. [Beyond antibiotic therapy – Future antiinfective strategies – Update 2017]. Unfallchirurg 2017;120:573-84.
16. Wittmann J, Dreiseikelmann B, Rohde C, Rohde M, Sikorski J. Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans. PLoS One 2014;9:e86935.
17. Wittmann J, Dreiseikelmann B, Rohde M, Meier-Kolthoff JP, Bunk B, Rohde C. First genome sequences of Achromobacter phages reveal new members of the N4 family. Virol J 2014;11:14.